László Halász

11PUBLICATIONS
108CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer.

|May 22, 2026
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases.

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

|Apr 01, 2025
Setdb2 Regulates Inflammatory Trigger-Induced Trained Immunity of Macrophages Through Two Different Epigenetic Mechanisms.

Anant Jaiswal, Laszlo Halasz, David L Williams

|Sep 05, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis.

Matthew D Park, Jessica Le Berichel, Pauline Hamon

|Jan 11, 2024
An Atlas of Promoter Chromatin Modifications and HiChIP Regulatory Interactions in Human Subcutaneous Adipose-Derived Stem Cells.

Laszlo Halasz, Adeline Divoux, Katalin Sandor

Pageof 2

Frequent Collaborators

4 joint publications

Miriam Merad

4 joint publications

Raphaël Mattiuz

3 joint publications

Leanna Troncoso

3 joint publications

Pauline Hamon